Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

26.46
Delayed Data
As of Sep 28
 +0.02 / +0.08%
Today’s Change
16.75
Today|||52-Week Range
41.77
-19.87%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Mellett Paul J
Chief Financial Officer & Treasurer
Sale10/15/20157,500$40.10$300.8K-34.96%
Mellett Paul J
Chief Financial Officer & Treasurer
Sale11/24/20155,899$30.13$177.7K-14.09%
Or Yat Sun
Chief Scientific Officer
Buy1/04/201650,723$2.97$150.6K-22.61%
Luly Jay R
President & Chief Executive Officer
Buy6/10/201641,645$2.97$123.7K+13.42%
Luly Jay R
President & Chief Executive Officer
Buy5/10/201625,000$2.97$74.3K+7.91%
Or Yat Sun
Chief Scientific Officer
Buy1/19/201623,201$2.54$58.9K+2.24%
Vance Terry
Director
Buy2/12/20162,000$27.04$54.1K-0.90%
Luly Jay R
President & Chief Executive Officer
Buy3/09/201618,561$2.54$47.1K-7.35%
Luly Jay R
President & Chief Executive Officer
Buy10/23/201518,561$1.98$36.8K+10.20%
Or Yat Sun
Chief Scientific Officer
Buy1/19/201613,921$2.54$35.4K+2.24%
Page of 2